Hongbin Han Selected Research

Hongbin Han Research Topics

Disease

6	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 10/2015
6	Neoplasms (Cancer) 02/2023 - 08/2014
4	Parkinson Disease (Parkinson's Disease) 01/2024 - 02/2016
2	Brain Diseases (Brain Disorder) 01/2024 - 12/2022
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 11/2022
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022 - 08/2016
2	Ischemic Stroke 01/2020 - 01/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 03/2011
2	Gliosis 01/2019 - 02/2016
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2016 - 02/2012
2	Herpes Zoster 10/2014 - 03/2014
1	Nervous System Diseases (Neurological Disorders) 01/2024
1	Stroke (Strokes) 01/2024
1	Movement Disorders (Movement Disorder) 10/2023
1	Liver Neoplasms (Liver Cancer) 02/2023
1	Breast Neoplasms (Breast Cancer) 11/2022
1	Bites and Stings (Sting) 11/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2022
1	Dementia (Dementias) 01/2022
1	Granuloma 01/2022
1	Ataxia (Dyssynergia) 01/2021
1	Necrosis 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Cerebral Infarction 01/2020
1	Reperfusion Injury 01/2020
1	Sarcosinemia 01/2019
1	Brain Injuries (Brain Injury) 01/2016
1	Adenocarcinoma 08/2014
1	Glioma (Gliomas) 05/2013
1	Hemorrhage 02/2012
1	Intracranial Vasospasm 02/2012
1	Muscle Spasticity (Spastic) 02/2012
1	Brain Neoplasms (Brain Tumor) 07/2011
1	Infarction (Infarctions) 03/2011

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2015
4	Gadolinium DTPA (Magnevist)FDA Link 01/2022 - 07/2011
3	ProdrugsIBA 02/2023 - 11/2022
3	FlavonoidsIBA 10/2022 - 02/2016
3	Neuroprotective AgentsIBA 01/2020 - 02/2016
2	DNA (Deoxyribonucleic Acid)IBA 02/2023 - 11/2022
2	Cisplatin (Platino)FDA LinkGeneric 02/2023 - 11/2022
2	PlatinumIBA 02/2023 - 11/2022
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2023 - 11/2022
2	CamptothecinIBA 01/2023 - 11/2022
2	RotenoneIBA 10/2022 - 08/2016
2	GadoliniumIBA 01/2022 - 01/2020
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2019
2	OccludinIBA 10/2014 - 03/2014
2	Claudin-5IBA 10/2014 - 03/2014
2	Tight Junction ProteinsIBA 10/2014 - 03/2014
1	Alkylating AgentsIBA 02/2023
1	Ubiquitin-Specific ProteasesIBA 02/2023
1	DisulfidesIBA 02/2023
1	PolymersIBA 02/2023
1	LipidsIBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Long Noncoding RNAIBA 12/2022
1	Untranslated RNA (Noncoding RNA)IBA 12/2022
1	pyrotinibIBA 11/2022
1	dalpiciclibIBA 11/2022
1	Letrozole (Femara)FDA LinkGeneric 11/2022
1	Nanoparticle Drug Delivery SystemIBA 11/2022
1	SuspensionsIBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2022
1	Formaldehyde poisoningIBA 01/2022
1	glutathione-independent formaldehyde dehydrogenase (formaldehyde dehydrogenase)IBA 01/2022
1	thymoquinoneIBA 01/2020
1	AldehydesIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	SolutionsIBA 11/2016
1	Human Serum Albumin FDA LinkGeneric 11/2016
1	gadoteridol (Prohance)FDA Link 11/2016
1	FullerenesIBA 11/2016
1	NeurotoxinsIBA 02/2016
1	kaempferolIBA 02/2016
1	Oxidopamine (6 Hydroxydopamine)IBA 02/2016
1	SynucleinsIBA 02/2016
1	rhyncophyllineIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 10/2015
1	Phospholipid Transfer ProteinsIBA 10/2015
1	MicellesIBA 08/2014
1	tricineIBA 08/2014
1	triphenylphosphineIBA 08/2014
1	Sepharose (Agarose)IBA 05/2013
1	AcidsIBA 05/2013
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 02/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2012
1	salicylhydroxamic acid (SHAM)IBA 02/2012
1	polypeptide 1 70kD ribosomal protein S6 kinaseIBA 02/2012
1	TOR Serine-Threonine KinasesIBA 02/2012
1	Cytidine Diphosphate Choline (Citicoline)IBA 03/2011

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2019
1	Phototherapy (Light Therapy) 01/2024
1	Resistance Training 10/2023
1	Immunotherapy 11/2022
1	Drug Therapy (Chemotherapy) 11/2022
1	Low-Level Light Therapy (LLLT) 09/2021
1	Intraperitoneal Injections 03/2011